Life Sciences

Amgen rewarded for bold DJ strategy in biosimilar dispute with Genentech

Delaware district court sides with biopharma giant in first cancer biosimilar suit, which is being watched closely in life sciences sector

Amgen rewarded for bold DJ strategy in biosimilar dispute with Genentech
20 Feb 2020

IP policy to take centre stage as Trump visits India 

Modi cabinet approves memorandum of understanding on IP policy issues ahead of the American president’s visit next week, but it may not address the reforms multinationals are hoping for

19 Feb 2020

A deep dive into global innovation landscape emphasises the need for collaboration

Working together to develop new products is becoming a new business imperative, according to Clarivate’s latest top 100 global innovators report

Latest

View all
18 Feb 2020

IPR slump leads to fall in PTAB caseloads for top 20 US law firms

Fish and Sterne Kessler still lead, but both saw reductions in the number of reviews they handled in 2019 Read more

18 Feb 2020

Tell us what you think of the latest developments in the global IP market

IAM's annual IP benchmarking survey opens today Read more

18 Feb 2020

UK Supreme Court case could have big impact on biotech IP strategies

A much-watched dispute over Regeneron transgenic mice patents will affect when and how life sciences innovators seek protection for their increasingly complex inventions Read more

17 Feb 2020

The keys to securing diagnostic method claims patents in the US

Understanding three significant Federal Circuit rulings – and then following clear procedural advice – could make the difference between success and failure Read more

News

View all
15 Feb 2020

The impact of Covid-19 will be felt across the global IP market

The race to patent a treatment for coronavirus in China is heating up, but its spread could be the story that affects every other story in tech this year Read more

14 Feb 2020

Help to choose the IP Hall of Fame inductees for 2020

Nominate someone who deserves recognition for their outstanding, long-term contribution to the IP world Read more

12 Feb 2020

Cause for concern in German patent reform proposals

Changes to the injunctive relief regime suggested by the Ministry of Justice in a recent discussion paper could significantly weaken IP owners’ rights Read more

8 Feb 2020

The inconvenient truth is that the West gifted China its 5G leadership

A lack of foresight and a complete absence of joined up thinking in both the US and Europe have handed Huawei and others huge advantages in a technology space that is set to change the world Read more

Analysis

View all
14 Feb 2020

In surprise reversal, Indonesia to scrap patent working requirement

Sweeping economic reform package backed by president Jokowi will deliver a big win for patent owners in Southeast Asia’s biggest market Read more

13 Feb 2020

Gilead suffers setback in controversial $1 billion patent dispute with US government

A loss for the Californian company in the high-profile case could lead to a more proactive IP strategy from the federal government Read more

13 Feb 2020

TSMC surge fuels increase in patenting by Taiwanese companies

Alibaba continues to outpace semiconductor players as the biggest patent filer from outside the island Read more

11 Feb 2020

Antitrust considerations now a much bigger factor in pharma patent dealmaking

Following recent forced divestments - and with growing political concern about life sciences acquisitions - the signs are that regulators will play a larger role in transactions Read more

Insights

View all
29 Nov 2019

IP market news highlights

IAM’s biggest autumn reads Read more

24 May 2019

IP market news highlights

Some of the major news stories carried on the IAM platform from March to mid-May. Read more

1 Apr 2019

IP market news highlights

The big stories from the IAM platform in February and March. Read more